Abstract
Introduction: Persistent human papillomavirus (HPV) semen infection is increasingly associated with male infertility. Adjuvant HPV vaccination is suggested to reduce the time to clearance and the disease relapse in males with persistent HPV semen infection. However, only a sub-population of patients show a clinical benefit from adjuvant vaccination. Here, we aimed to address the effectiveness rate of HPV adjuvant vaccination in males with genital tract infection and the possible prognostic markers of healing. Methods: Clinical records from 379 patients with persistent seminal HPV detection, all receiving HPV adjuvant vaccination, were considered. Clinical data, including genital HPV-DNA assessment by INNO-LiPA genotyping, semen HPV-DNA analysis by FISH analysis and serum antibody titer, were collected at basal (T0) and after 6 months (T1) since the vaccination cycle ended. Results: Clearance of genital HPV-DNA was recorded in 326 (86%) patients. Serum HPV-antibody titer at T1 was the most important prognostic factor associated with HPV-DNA clearance. A serum antibody titer equal to or greater than the threshold value 1:125, obtained by ROC curve analysis, was prognostic of healing. Conclusions: Anti-HPV antibody represents a suitable marker of adequate immune response to HPV vaccination in patients with genital infection.
Highlights
Persistent human papillomavirus (HPV) semen infection is increasingly associated with male infertility
This condition has been associated with worsened sperm motility and higher incidence of anti-sperm antibodies (ASAs) compared to fertile men, suggesting a major role of HPV infection in male infertility [4,5,6]
Among males attending our unit for andrological issues, we retrospectively considered the clinical and demographic records from 700 patients with genital and/or semen HPV detection and genotyping
Summary
Persistent human papillomavirus (HPV) semen infection is increasingly associated with male infertility. Methods: Clinical records from 379 patients with persistent seminal HPV detection, all receiving HPV adjuvant vaccination, were considered. In addition to male genital areas, an increasing number of studies reported the detection of HPV virions in whole semen and even bound to the sperm cells [3,4]. This condition has been associated with worsened sperm motility and higher incidence of anti-sperm antibodies (ASAs) compared to fertile men, suggesting a major role of HPV infection in male infertility [4,5,6].
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
